Development of a Fascial Training Based Mobile Application and Investigation of Its Effectiveness in Patients With Disc Herniation
Launched by BASKENT UNIVERSITY · Jul 1, 2025
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
In the study, 20 people in three different groups with a drop-out rate of twenty percent will participate in the study. This number is 60 people in total.
In the study, fascia exercises will be applied at home with the mobile application named Fascia-M for the first group, fascia exercises will be applied at home with the home brochure for the second group, and lumbar stabilization exercises will be applied at home with the home brochure for the third group. Visual pain scale, Tampa kinesiophobia scale, SF-12 Quality of Life Questionnaire, Pittsburg Sleep Quality Scale, modified schober te...
Gender
ALL
Eligibility criteria
- Exclusion Criteria:
- • Mobile on Android devices have the competence to use the application
- • No neurological deficit
- • painkillers during the treatment process
- • They are volunteer individuals who do not use medication
- İnclusion Criteria:
- • speak Turkish, and have Turkish literacy.
- • included lumbar
- • diagnosed with disc herniation with doctor's diagnosis
- • participants is between the ages of 20-55,
- • able to use mobile technology
- • willing to participate in the study individuals with
About Baskent University
Baskent University is a distinguished academic and research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on evidence-based medicine, the university collaborates with a network of healthcare professionals and researchers to design and implement rigorous clinical research that aims to improve patient outcomes. Baskent University is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives while fostering a collaborative environment that promotes scientific discovery and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported